Literature DB >> 7626063

Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata.

J Laredo1, B P Hamilton, J M Hamlyn.   

Abstract

Recent experiments have demonstrated the secretion of a ouabain-like compound from primary cultures of bovine adrenocortical cells (1). To determine the relative contribution of the outer zones of the adrenal cortex to the secretion of endogenous ouabain, we measured the content of this steroid in zona glomerulosa and zona fasciculata tissue freshly excised from bovine adrenals and in the secretion media of primary cell cultures derived from these zones. The tissue content of endogenous ouabain was 5.7-fold higher in the zona glomerulosa than in the zona fasciculata. The concentration of endogenous ouabain was 4.1-fold higher in 24-hour conditioned media from zona glomerulosa than in zona fasciculata cultures. Angiotensin II and ACTH stimulated the secretion of endogenous ouabain from zona glomerulosa cultures, but had no effect on zona fasciculata cultures. These findings suggest that endogenous ouabain is primarily synthesized and secreted from the adrenal zona glomerulosa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626063     DOI: 10.1006/bbrc.1995.1996

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function.

Authors:  D Lichtstein; H Rosen
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 2.  An update on the relationship between the kidney, salt and hypertension.

Authors:  Gert Mayer
Journal:  Wien Med Wochenschr       Date:  2008

Review 3.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 4.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 5.  Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.

Authors:  Mordecai P Blaustein; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-06

6.  A new clinical multivariable model that predicts postoperative acute kidney injury: impact of endogenous ouabain.

Authors:  Marco Simonini; Chiara Lanzani; Elena Bignami; Nunzia Casamassima; Elena Frati; Roberta Meroni; Elisabetta Messaggio; Ottavio Alfieri; John Hamlyn; Simon C Body; C David Collard; Alberto Zangrillo; Paolo Manunta
Journal:  Nephrol Dial Transplant       Date:  2014-06-11       Impact factor: 5.992

7.  Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent.

Authors:  A Sophocleous; I Elmatzoglou; A Souvatzoglou
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 8.  Endogenous Ouabain: Recent Advances and Controversies.

Authors:  John M Hamlyn; Mordecai P Blaustein
Journal:  Hypertension       Date:  2016-07-25       Impact factor: 10.190

9.  Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patients.

Authors:  Elena Bignami; Nunzia Casamassima; Elena Frati; Chiara Lanzani; Laura Corno; Ottavio Alfieri; Stephen Gottlieb; Marco Simonini; Keyur B Shah; Anna Mizzi; Elisabetta Messaggio; Alberto Zangrillo; Mara Ferrandi; Patrizia Ferrari; Giuseppe Bianchi; John M Hamlyn; Paolo Manunta
Journal:  Crit Care Med       Date:  2013-03       Impact factor: 7.598

10.  Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance.

Authors:  Jin Zhang; John M Hamlyn; Eiji Karashima; Hema Raina; Joseph R H Mauban; Michelle Izuka; Roberto Berra-Romani; Alessandra Zulian; W Gil Wier; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.